Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

76.81
Delayed Data
As of 4:01pm ET
 -0.03 / -0.04%
Today’s Change
64.18
Today|||52-Week Range
83.79
+4.43%
Year-to-Date
What's in Store for Abbott Labs (ABT) This Earnings Season?
6:35pm / Zacks.com - Paid Partner Content
Here's Why CoLucid Pharmaceuticals Inc Popped Yesterday
Jan 19 / MotleyFool.com - Paid Partner Content
Camelot Portfolios, LLC Buys MTGE Investment Corp, AGNC Investment Corp, US Bancorp, ...
4:41pm / GuruFocus News - Paid Partner Content
Vertex Pharma (VRTX) Q4 Earnings: Stock Likely to Beat?
Jan 19 / Zacks.com - Paid Partner Content
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint?
3:32pm / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Q4 Earnings: Will the Stock Disappoint?
Jan 19 / Zacks.com - Paid Partner Content
4 Drug Stocks Poised to Surprise this Earnings Season
3:19pm / Zacks.com - Paid Partner Content
Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?
Jan 19 / Zacks.com - Paid Partner Content
Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise?
9:20am / Zacks.com - Paid Partner Content
Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout
Jan 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close76.84
Today’s open77.11
Day’s range76.47 - 77.41
Volume4,371,196
Average volume (3 months)5,414,469
Market cap$84.8B
Dividend yield2.71%
Data as of 4:01pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+1.35%
Earnings growth (this year)+3.31%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+1.75%
P/E ratio33.4
Price/Sales4.50
Price/Book5.83

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-0.96-0.84%
AGNAllergan-0.24-0.11%
BMYBristol-Myers Squibb-6.26-11.28%
GSKGlaxoSmithKline-0.03-0.08%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.98
Annual revenue (last year)$20.0B
Annual profit (last year)$2.4B
Net profit margin12.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
David A. Ricks
Chief Financial Officer &
EVP-Global Services
Derica W. Rice
Corporate headquarters
Indianapolis, Indiana

Forecasts


Search for Jobs